Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: a systematic review and meta-analysis

被引：0
|
作者：
Zhi-hui Zhang
Xin-yue Lian
Dong-ming Yao
Pin-fang He
Ji-chun Ma
Zi-jun Xu
Hong Guo
Wei Zhang
Jiang Lin
Jun Qian
机构：
[1] Affiliated People’s Hospital of Jiangsu University,Department of Hematology
[2] Affiliated People’s Hospital of Jiangsu University,Laboratory Center
[3] The Key Lab of Precision Diagnosis and Treatment of Zhenjiang City,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2017年 / 143卷
关键词：
Reduced intensity conditioning; Stem cell transplantation; Elderly; Myelodysplastic syndrome; Acute myeloid leukemia; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1853 / 1864
页数：11
相关论文
共 50 条
  • [41] Hematopoietic cell transplantation after reduced-intensity conditioning for older adults with acute myeloid leukemia in complete remission
    Baron, Frederic
    Storb, Rainer
    CURRENT OPINION IN HEMATOLOGY, 2007, 14 (02) : 145 - 151
  • [42] Hypomethylating Agents and FLT3 Inhibitors As Maintenance Treatment for Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation-A Systematic Review and Meta-Analysis
    Bewersdorf, Jan Philipp
    Allen, Cecily
    Mirza, Abu-Sayeef
    Grimshaw, Alyssa A.
    Giri, Smith
    Podoltsev, Nikolai A.
    Gowda, Lohith
    Cho, Christina
    Tallman, Martin S.
    Zeidan, Amer M.
    Stahl, Maximilian
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (12): : 997.e1 - 997.e11
  • [43] Acute myeloid leukemia and reduced-intensity conditioning allogeneic stem cell transplantation: where do we stand?
    Pautas, Cecile
    Maury, Sebastien
    Kuentz, Mathieu
    Hicheri, Yosr
    Ben Amor, Ramzi
    Cordonnier, Catherine
    HEMATOLOGIE, 2007, 13 (01): : 54 - 64
  • [44] Maintenance therapy with hypomethylating agents for patients with acute myeloid leukemia in first remission not eligible for allogeneic hematopoietic cell transplantation: A systematic review and meta-analysis
    Sherban, A.
    Raanani, P.
    Gurion, R.
    Wolach, O.
    Gafter-Gvili, A.
    LEUKEMIA RESEARCH, 2022, 113
  • [45] Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated myelodysplastic syndrome: A systematic review and meta-analysis
    Shahzad, Moazzam
    Iqbal, Qamar
    Tariq, Ezza
    Ammad-Ud-Din, Mohammad
    Butt, Atif
    Mushtaq, Ali Hassan
    Ali, Fatima
    Chaudhary, Sibgha Gull
    Anwar, Iqra
    Gonzalez-Lugo, Jesus D.
    Abdelhakim, Haitham
    Ahmed, Nausheen
    Hematti, Peiman
    Singh, Anurag K.
    Mcguirk, Joseph P.
    Mushtaq, Muhammad Umair
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 196
  • [46] Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia:: disease status by marrow blasts is the strongest prognostic factor
    Sayer, HG
    Kröger, M
    Beyer, J
    Kiehl, M
    Klein, SA
    Schaefer-Eckart, K
    Schwerdtfeger, R
    Siegert, W
    Runde, V
    Theuser, C
    Martin, H
    Schetelig, J
    Beelen, DW
    Fauser, A
    Kienast, J
    Höffken, K
    Ehninger, G
    Bornhäuser, M
    BONE MARROW TRANSPLANTATION, 2003, 31 (12) : 1089 - 1095
  • [47] Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and over
    Santoro, Nicole
    Labopin, Myriam
    Ciceri, Fabio
    Van Lint, Maria Teresa
    Nasso, Daniela
    Blaise, Didier
    Arcese, William
    Tischer, Johanna
    Bruno, Benedetto
    Ehninger, Gerhard
    Koc, Yener
    Santarone, Stella
    Huang, Xiao-Jun
    Savani, Bipin N.
    Mohty, Mohamad
    Ruggeri, Annalisa
    Nagler, Arnon
    CANCER, 2019, 125 (09) : 1499 - 1506
  • [48] Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor
    H G Sayer
    M Kröger
    J Beyer
    M Kiehl
    S A Klein
    K Schaefer-Eckart
    R Schwerdtfeger
    W Siegert
    V Runde
    C Theuser
    H Martin
    J Schetelig
    D W Beelen
    A Fauser
    J Kienast
    K Höffken
    G Ehninger
    M Bornhäuser
    Bone Marrow Transplantation, 2003, 31 : 1089 - 1095
  • [49] Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia
    Krejci, Marta
    Doubek, Michael
    Dusek, Jaroslav
    Brychtova, Yvona
    Racil, Zdenek
    Navratil, Milan
    Tomiska, Miroslav
    Horky, Ondrej
    Pospisilova, Sarka
    Mayer, Jiri
    ANNALS OF HEMATOLOGY, 2013, 92 (10) : 1397 - 1403
  • [50] Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia
    Lee, Seung-Shin
    Jung, Sung-Hoon
    Do, Young Rok
    Kim, Dae Sik
    Lee, Ji Hyun
    Park, Han-Seung
    Moon, Joon Ho
    Yi, Jun Ho
    Park, Yong
    Koh, Youngil
    Yhim, Ho-Young
    Choi, Yunsuk
    Mun, Yeung-Chul
    Lee, Won-Sik
    Lee, Seok
    Yang, Deok-Hwan
    YONSEI MEDICAL JOURNAL, 2020, 61 (06) : 452 - 459
12345